No Detail Found!

Combination therapy with Baofukang suppositories and promestriene cream for postmenopausal atrophic vaginitis: A randomized controlled trial

Author(s)
Jingjing Wang Department of Gynecology and Obstetrics, Beijing Longfu Hospital,Beijing,China
Shuya Yang Department of Medical Genetics and Prenatal Diagnosis, Zhoukou Maternal and Child Health Care Hospital,Zhoukou, Henan,China
Shujun Yan Department of Pregnancy Health Care, Zhoukou Maternal and Child Health Care Hospital,Zhoukou, Henan,China
Abstract
Postmenopausal atrophic vaginitis is a prevalent condition that significantly impacts the quality of life. This study aimed to evaluate the efficacy and safety of combining Baofukang suppositories with Promestriene cream in treating this condition, with a particular focus on clinical outcomes and endometrial thickness. Sixty-eight patients underwent random allocation into either the control group (Baofukang suppositories) or the observational group (Baofukang suppositories and Promestriene cream). Endometrial thickness was measured using transvaginal ultrasound, and clinical indicators, including symptom resolution time, vaginal cleanliness, and adverse reactions, were assessed. The observational group showed a higher effective rate (97.06% vs. 79.41%, P0.05). Combining Baofukang suppositories with Promestriene cream offers an effective and safe therapeutic option for postmenopausal atrophic vaginitis, promoting superior symptom recovery without compromising endometrial safety.
Publication Details
Page(s) 151-156
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Endometrial thickness, Perimenopause, atrophic vaginitis, promestriene cream, Baofukang suppositories
References
Alexiades MR .2021 .Fractional Co(2) Laser treatment of the vulva and vagina and the effect of postmenopausal duration on efficacy. Lasers Surg. Med, 53(2) : 185-198.
Benini V,Ruffolo AF,Casiraghi A,Degliuomini RS,Frigerio M,Braga A,Serati M,Torella M,Candiani M,Salvatore S M .2022 .New innovations for the treatment of vulvovaginal atrophy: An up-to-date review. Medicina (Kaunas), 58(6) : 770.
Bleibel B,Nguyen H B .2023 .Vaginal atrophy. In: Stat Pearls Stat Pearls Publishing, Treasure Island (FL)., : .
De Oliveira NS,de Lima ABF,de Brito JCR,Sarmento ACA,Goncalves AKS,Eleuterio JJr AKS .2021 .Postmenopausal vaginal microbiome and microbiota. Front. Reprod. Health, 3 : 780931.
Donders GGG,Donders F GGG .2023 .New developments in the management of vulvovaginal atrophy: A comprehensive overview. Expert Opin, 24(5) : 599-616.
He C,Song C,Li M,Ma W,Sun S W .2022 .Metaanalysis of the effect and safety of recombinant human interferon alpha-2b combined with Baofukang suppository in the treatment of HPV infection. Am. J. Transl. Res., 14(11) : 7632-7642.
Ilhan G,Aslan MM,Cevrioglu AS,Yıldırım M,Erkorkmaz U M .2021 .Clinical efficacy of hormonal and nonhormonal agents in the treatment of vulvovaginal atrophy. J. Menopausal Med, 27(1) : 15-23.
Karlson K,Fishburn D,Shvartsman K,Elling S,Snitchler A,Keung E .2023 .In a pinch: An unusual case of Zoon's vaginitis, a plasma cell disorder. Cureus, 15(8) : e43260.
Langella D .2023 .Plurigin ovules and plurigin solution in the treatment of vulvovaginal atrophy in menopausal women: A retrospective monocentric observational study. Medicina (Kaunas), 59(6) : 1108.
Le C,Murgia RD,Noell C,Weiss M and Weiss R C .2022 .Female genitourinary treatments in aesthetics. Clin. Dermatol, 40(3) : 259-264.
Maffei S and Guiducci L .2022 .Effect of ospemifene on densitometric and plasma bone metabolism biomarkers in postmenopausal women reporting vulvar and vaginal atrophy (VVA). J. Clin. Med, 11(21) : 6316.
Mesbahi A,Mohammad-Alizadeh-Charandabi S,Ghorbani Z,Mirghafourvand M .2022 .The effect of intra-vaginal oxytocin on sexual function in breastfeeding mothers: A randomized triple-blind placebo-controlled trial. BMC Pregnancy Childbirth, 22(1) : 62.
.2024 .Menopause: Identification and management. , : .
Paciuc J .2020 .Hormone therapy in menopause. Adv. Exp. Med, 1242 : 89-120.
Palacios S,Nappi RE,Cancelo MJ,Sanchez S,Simoncini T .2023 .Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence. Climacteric, 26(4) : 388-391.
Panay N,Ang SB,Cheshire R,Goldstein SR,Maki P,Nappi RE .2024 .Menopause and MHT in 2024: addressing the key controversies -. International Menopause Society White Paper. Climacteric, 27(5) : 441-457.
Rioux JE,Devlin MC,Gelfand MM,Steinberg WM,Hepburn DS .2018 .17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause, 25(11) : 1208-1213.
Sanchez-Borrego R,Manubens M,Navarro MC,Cancelo MJ,Beltran E,Duran M,Orte T,Baquedano L,Palacios S,Mendoza N S .2014 .Position of the Spanish Menopause Society regarding vaginal health care in postmenopausal women. Maturitas, 78(2) : 146-150.
Sarmento ACA,Kamilos MF,Costa APF,Vieira-Baptista P,Eleuterio J,Goncalves AK J .2021 .Use of moisturizers and lubricants for vulvovaginal atrophy. Front. Reprod. Health, 3 : 781353.
Segal S,Harvie HS,Siegelman E,Arya LA .2011 .Severe atrophic vaginitis causing vaginal synechiae and hematocolpos at menopause. Menopause, 18(3) : 333-335.
Sun AJ,Lin SQ,Jing LH,Wang ZY,Ye JL,Zhang Y .2009 .Safety of promestriene capsule used in postmenopausal atrophic vaginitis. Zhonghua Fu Chan Ke. Za. Zhi., 44(8) : 593-596.
Talaulikar V .2022 .Menopause transition: Physiology and symptoms. Best Pract. Res. Clin. Obstet, 81 : 3-7.
Wang YQ,Guo X,Shan T .2010 .Clinical effect of xianling gubao capsule combined with baofukang suppository in treating atrophic vaginitis. Zhongguo Zhong Xi Yi Jie He Za Zhi, 30(7) : 766-768.
Wierzbicka A,Mańkowska-Wierzbicka D,Cieślewicz S,Stelmach-Mardas M,Mardas M M .2021 .Interventions preventing vaginitis, vaginal atrophy after brachytherapy or radiotherapy due to malignant tumors of the female reproductive organs-a systematic review. Int. J. Environ. Res. Public Health, 18(8) : 3932.
Xu X,Liu Y,Feng W,Shen J .2024 .Strong evidence supports the use of estradiol therapy for the treatment of vaginal inflammation: A two-way Mendelian randomization study. Eur. J. Med Res., 29(1) : 339.
0

Citations

0

Downloads

88

Views